2007
DOI: 10.1590/s1980-57642008dn10400002
|View full text |Cite
|
Sign up to set email alerts
|

Neuroprotective actions of 2,4-dinitrophenol: Friend or foe?

Abstract: 2,4-dinitrophenol (DNP) has long been known to be toxic at high concentrations, an effect related to uncoupling of mitochondrial oxidative phosphorylation. Five years ago, however, we reported that low concentrations of DNP protect neurons against the toxicity of the amyloid-β peptide. Since then, a number of other studies have provided evidence of beneficial actions of DNP (at low concentrations), including neuroprotection against different types of insult, blockade of amyloid aggregation, stimulation of neur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 38 publications
(45 reference statements)
0
2
0
Order By: Relevance
“…Consequently, inhibition of the MPT is a promising target in neuroprotection 3 . On the other hand, depolarization of mitochondria is widely used a predictor of toxicity 72 but depolarization connected with uncoupling of the respiratory chain or stimulation of electron flux can also be cytoprotective 73 . Due to its redox-cycling capability, MB can restore the electron flux in the respiratory chain in the presence of inhibitors of complex-I 74 .…”
Section: Resultsmentioning
confidence: 99%
“…Consequently, inhibition of the MPT is a promising target in neuroprotection 3 . On the other hand, depolarization of mitochondria is widely used a predictor of toxicity 72 but depolarization connected with uncoupling of the respiratory chain or stimulation of electron flux can also be cytoprotective 73 . Due to its redox-cycling capability, MB can restore the electron flux in the respiratory chain in the presence of inhibitors of complex-I 74 .…”
Section: Resultsmentioning
confidence: 99%
“…When administered at low doses, DNP has been shown to reduce oxidative damage and increase longevity in mice [45]. It has also demonstrated potential antiamyloidogenic and neuritogenic actions in vitro [46,47,48]. These in vitro studies and the in vivo experiments with mice are, by necessity, short term while the lifespan of a human neuron is in the order of decades.…”
Section: Uncouplingmentioning
confidence: 99%
“…However, the toxicity of high‐dose usage of DNP was shortly confirmed and the compound never obtained FDA approval as a therapeutic drug (Colman, 2007; Grundlingh et al., 2011). Over the last decade, accumulating evidence indicates that low‐dose DNP is neuroprotective (De Felice & Ferreira, 2006; De Felice et al., 2001; Ferreira & Felice, 2007; Geisler, 2019; Lee et al., 2017; Wasilewska‐Sampaio et al., 2005) and improves treatment outcomes for traumatic brain injury (Pandya et al., 2007). Mechanistically, apart from its traditional role as a proton ionophore to reduce ΔΨ m and inhibit mitochondrial Ca 2+ influx, low‐dose DNP suppresses the mammalian target of rapamycin (mTOR) pathway and stimulates the cAMP‐response element‐binding (CREB) protein–BDNF cascade, which is essential for synaptic plasticity, adaptive stress responses and cognitive function (Fernanda et al., 2007; Kandel et al., 2014; Liu et al., 2015).…”
Section: Introductionmentioning
confidence: 99%